SenesTech registers additional shares for at-the-market offering on Nasdaq

Published 30/06/2025, 13:24
SenesTech registers additional shares for at-the-market offering on Nasdaq

SenesTech, Inc. (NASDAQ:SNES), a small-cap company with a market value of $8.61 million, announced Monday that it has filed a prospectus supplement to register an additional $711,227 worth of its common stock for sale under its existing at-the-market (ATM) offering program. According to InvestingPro data, the company maintains more cash than debt on its balance sheet but is quickly burning through its cash reserves. The shares will be issued pursuant to the ATM agreement with H.C. Wainwright & Co., LLC, originally dated June 20, 2024.

According to the company’s statement in a Securities and Exchange Commission filing, SenesTech has previously sold an aggregate of $2,854,827.84 of its common stock through the sales agent under this agreement. The newly registered shares represent an expansion of the company’s ability to raise capital through open market transactions.

The company also filed a legal opinion from Greenberg Traurig, LLP regarding the validity of the shares covered by the prospectus supplement as an exhibit to the filing.

SenesTech’s common stock is listed on the Nasdaq Stock Market under the ticker symbol SNES. The information is based on a press release statement included in a recent SEC filing.

In other recent news, SenesTech reported a 17% increase in revenue for the first quarter of 2025, reaching $485,000. The company’s EVOLVE product line saw a notable 40% surge in sales, now making up 79% of total sales. Gross margins improved significantly to 64.5%, up from 32.5% the previous year, resulting in a 132% increase in gross profit. The company is targeting cash flow breakeven at $1.5 million in quarterly revenue. Additionally, SenesTech has been expanding its presence in municipal markets, with new deployments in cities like Chicago and New York. The company is also increasing its international footprint, having signed distribution agreements in 12 countries. SenesTech’s focus on high-margin products and market expansion initiatives are part of its strategic growth plan.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.